Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States

BACKGROUND: The prevalence of antimicrobial resistance among gram-negative pathogens in complicated intra-abdominal infections (cIAIs) has increased. In the absence of timely information on the infecting pathogens and their susceptibilities, local or regional epidemiology may guide initial empirical...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Resist Infect Control
Main Authors: Prabhu, Vimalanand S., Solomkin, Joseph S., Medic, Goran, Foo, Jason, Borse, Rebekah H., Kauf, Teresa, Miller, Benjamin, Sen, Shuvayu S., Basu, Anirban
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5658949/
https://ncbi.nlm.nih.gov/pubmed/29090091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13756-017-0264-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados